Literature DB >> 12864965

New approaches to the medical treatment of irritable bowel syndrome.

Driss Berrada1, Katia Canenguez, Tony Lembo.   

Abstract

Irritable bowel syndrome (IBS) is a common disorder with a worldwide distribution; it is characterized by abdominal pain and discomfort associated with an alteration of bowel function. The treatment approach for IBS depends on the patient's presenting symptoms at the time of diagnosis, and treatment is usually directed toward the predominant symptom. In this review we discuss the current approach to the treatment of IBS.

Entities:  

Mesh:

Year:  2003        PMID: 12864965     DOI: 10.1007/s11894-003-0072-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  43 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  Review article: tegaserod.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

3.  Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double blind randomised study).

Authors:  B M Tripathi; N P Misra; A K Gupta
Journal:  J Assoc Physicians India       Date:  1983-04

4.  Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials.

Authors:  F Cremonini; S Delgado-Aros; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2003-02       Impact factor: 3.598

5.  Symptom relief with amitriptyline in the irritable bowel syndrome.

Authors:  M Rajagopalan; G Kurian; J John
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

6.  Loperamide treatment of the irritable bowel syndrome.

Authors:  N Hovdenak
Journal:  Scand J Gastroenterol Suppl       Date:  1987

7.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

Authors:  J Kellow; O Y Lee; F Y Chang; S Thongsawat; M Z Mazlam; H Yuen; K A Gwee; Y T Bak; J Jones; A Wagner
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.

Authors:  John M Hebden; Elaine Blackshaw; Massimo D'Amato; Alan C Perkins; Robin C Spiller
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

10.  Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.

Authors:  S A Müller-Lissner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.